Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315900 · ClinicalTrials.gov registry record · Phase 3
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
A Phase 3 study, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- Terminated
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT00315900 is a Phase 3 study that was terminated before completion, run by Tuscaloosa Research & Education Advancement Corporation. The registered enrollment target is 20 participants.
The verdict
NCT00315900, a Phase 3 study, was terminated before completion, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary objective of the study is to assess the relative efficacy of Depakote ER and Seroquel for agitated behaviors among veterans with a dementia diagnosis residing in a Department of Veterans Affairs (VA) nursing home care unit (NHCU). The secondary objective of the study is to assess the relative tolerability of Depakote ER and Seroquel in this population. The primary hypothesis is that agitated dementia patients will demonstrate a significantly greater reduction in Cohen-Mansfield Agitation Inventory (CMAI) scores while treated with Depakote ER compared to treatment with Seroquel.
Interventions
- DRUG Depakote ER
- DRUG Seroquel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-05-01 |
| Est. Completion | 2008-02-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00315900
The ClinicalTrials.gov registry entry for NCT00315900 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tuscaloosa Research & Education Advancement Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Depakote ER is the first listed.
NCT00315900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00315900 about?
NCT00315900 is a clinical study titled "Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia". The primary objective of the study is to assess the relative efficacy of Depakote ER and Seroquel for agitated behaviors among veterans with a dementia diagnosis residing in a Department of Veterans Affairs (VA) nursing home care unit (NHCU). The secondary objective of the study is to assess the rel...
What is the current status of trial NCT00315900?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2006-05-01. Estimated completion is 2008-02-28.
What interventions are being tested in trial NCT00315900?
The interventions under investigation include: Depakote ER (DRUG), Seroquel (DRUG).
Who is sponsoring clinical trial NCT00315900?
This trial is sponsored by Tuscaloosa Research & Education Advancement Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.